FDA Label for Roycederm Seborrheic Dermatitis And Dandruff Medicated Cleansing Bar
View Indications, Usage & Precautions
- OTC - ACTIVE INGREDIENT
- OTC - PURPOSE
- DOSAGE & ADMINISTRATION
- WARNINGS
- OTC - ASK DOCTOR
- OTC - WHEN USING
- OTC - STOP USE
- OTC - PREGNANCY OR BREAST FEEDING
- OTC - KEEP OUT OF REACH OF CHILDREN
- INDICATIONS & USAGE
- OTHER SAFETY INFORMATION
- INACTIVE INGREDIENT
- OTC - QUESTIONS
- PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
Roycederm Seborrheic Dermatitis And Dandruff Medicated Cleansing Bar Product Label
The following document was submitted to the FDA by the labeler of this product Roycederm Llc. The document includes published materials associated whith this product with the essential scientific information about this product as well as other prescribing information. Product labels may durg indications and usage, generic names, contraindications, active ingredients, strength dosage, routes of administration, appearance, warnings, inactive ingredients, etc.
Otc - Active Ingredient
Pyrithione Zinc 2%
Otc - Purpose
- Anti-dandruff
- Anti-seborrheic dermatitis
Dosage & Administration
Controls and reduces the symptoms of dandruff and seborrheic dermatitis
Warnings
For external use only
Otc - Ask Doctor
you have a conditionthat covers a large area of the body.
Otc - When Using
avoid contact with eyesIf contact occurs, rinse thoroughly with water.
Otc - Stop Use
if condition worsensor does not improve.
Otc - Pregnancy Or Breast Feeding
ask a healthprofessional before use.
Otc - Keep Out Of Reach Of Children
In case of accidental ingestion, seek medical advice immediately or contact a Poison Control Center right away.(1-800-222-1222)
Indications & Usage
- Cleanse and dry skin.
- Apply a thin layer to affected areas.
- Use thricedaily or as directed by a doctor.
Other Safety Information
store at room temperature.
Inactive Ingredient
Tetrasodium EDTA, Sodium Cocoyl Isethionate, Glycerin, Polyquaternium-7, Menthol, Adep Bovis, Olea Europaea(Olive) fruit Oil, Butyrospermum Parkii (Shea Butter)
Otc - Questions
Email [email protected]
* Please review the disclaimer below.
